Companies: 10,795·Total market cap: $144.5T
BioVaxys Technology Corp.

BioVaxys Technology Corp.

BIOV.CNCNQHealthcare
$0.07
+$0.01(+16.67%)
Market Cap$2040675
P/E Ratio—
52W High$0.4
52W Low$0.03
PE RatioMarket CapForecast

BioVaxys Technology Corp. (BIOV.CN) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

biov.cn · pe ratio · data through Jun 10, 2026

Core PE Ratio Metrics

Trailing 12 months · TTM

Insufficient PE history data (fewer than 3 valid fiscal years).

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
BioVaxys Technology Corp.
BioVaxys Technology Corp.You
BIOV.CN
$2MN/A——
Aptose Biosciences Inc.
Aptose Biosciences Inc.
APS.TO
$6MN/A—-$10.59
Avant Brands Inc.
Avant Brands Inc.
AVNT.TO
$7MN/A—-$0.88
Ayurcann Holdings Corp.
Ayurcann Holdings Corp.
AYUR.CN
$2MN/A—-$0.02
BetterLife Pharma Inc.
BetterLife Pharma Inc.
BETR.CN
$11MN/A—-$0.01
Diagnamed Holdings Corp.
Diagnamed Holdings Corp.
DMED.CN
$5MN/A—-$0.02
Glow Lifetech Corp.
Glow Lifetech Corp.
GLOW.CN
$10MN/A—-$0.00

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for BioVaxys Technology Corp. (BIOV.CN) measures how much investors pay for each dollar of the company's trailing earnings. BIOV.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.07 by its TTM earnings per share of —.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.07 ÷ — = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.
Price historyFinancial statementsEarnings

Frequently asked questions

BIOV.CN pe ratio · 6 questions

BIOV.CN's current PE ratio is N/A as of 2026-06-10, based on a stock price of $0.07 and TTM EPS of —. Data sourced from Financial Modeling Prep via BIOV.CN's SEC 10-K and 10-Q filings.

BIOV.CN PE ratioWhat is BIOV.CN PE ratioCurrent PE ratio of BIOV.CNBIOV.CN PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BioVaxys Technology Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10